These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 22192935)

  • 1. [Kidney involvement in mixed cryoglobulinemia: which treatment?].
    Cacoub P
    Presse Med; 2012 Mar; 41(3 Pt 1):254-9. PubMed ID: 22192935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
    Garini G; Allegri L; Vaglio A; Buzio C
    Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection and glomerular disease.
    Fabrizi F; Donato F; Messa P
    Minerva Urol Nefrol; 2014 Jun; 66(2):139-49. PubMed ID: 24988205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia.
    Muro K; Toda N; Yamamoto S; Yanagita M
    Intern Med; 2021 Feb; 60(4):583-589. PubMed ID: 32999232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatitis C-related kidney disease.
    Fabrizi F; Martin P; Cacoub P; Messa P; Donato FM
    Expert Opin Pharmacother; 2015; 16(12):1815-27. PubMed ID: 26161511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term remission with rituximab in a patient with severe hepatitis C virus-induced mixed cryoglobulinemia.
    Fortea-Ormaechea JI; Lozano-Maya M; Adán-Merino L; Barrio-Antoranz J; Martín-Chavarri S; Corchete-Prats E; Martínez-Acebes E; Aldeguer-Martínez M
    Rev Esp Enferm Dig; 2013 Sep; 105(8):490-3. PubMed ID: 24274448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Delluc A; Piette JC; Cacoub P
    Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologist's puzzle: Membranoproliferative glomerulonephritis-like features in cryoglobulinemic glomerulonephritis.
    Kiremitci S; Calayoglu R; Ensari A; Erbay B
    Pathol Res Pract; 2012 Apr; 208(4):254-8. PubMed ID: 22381806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current therapeutic strategies for HCV-associated cryoglobulinemia].
    Iannuzzella F; Garini G
    Reumatismo; 2008; 60(3):163-73. PubMed ID: 18854876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful rituximab therapy of HCV-cryoglobulinemic vasculitis with severe ulcerative and necrotic lesions of the skin].
    Ignatova TM; Chernova OA; Gaĭdasheva EV
    Klin Med (Mosk); 2012; 90(5):64-6. PubMed ID: 22993956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-related cryoglobulinemic vasculitis: emerging trends in therapy.
    St Clair EW
    Arthritis Rheum; 2012 Mar; 64(3):604-8. PubMed ID: 22147537
    [No Abstract]   [Full Text] [Related]  

  • 12. [Difficulties in treatment of kidney diseases related to HCV infection].
    Jabłońska J; Kozłowska J
    Przegl Epidemiol; 2009; 63(1):75-8. PubMed ID: 19522231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.
    Sneller MC; Hu Z; Langford CA
    Arthritis Rheum; 2012 Mar; 64(3):835-42. PubMed ID: 22147444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dilemma of treating hepatitis C virus-associated cryoglobulinemia.
    Roccatello D; Fenoglio R; Sciascia S
    Curr Opin Rheumatol; 2019 Sep; 31(5):499-504. PubMed ID: 31090590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific damage to the kidneys in patients with chronic hepatitis C associated with cryoglobulinemia].
    Milovanova SIu; Tégaĭ SV; Russkikh AV; Kozlovskaia LV
    Ter Arkh; 2011; 83(11):38-43. PubMed ID: 22312883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryoglobulinemic membranoproliferative glomerulonephritis: beyond conventional therapy.
    Colucci G; Manno C; Grandaliano G; Schena FP
    Clin Nephrol; 2011 Apr; 75(4):374-9. PubMed ID: 21426893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hepatitis C-virus-related glomerulonephritis.
    Kamar N; Rostaing L; Alric L
    Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.
    De Vita S; Quartuccio L; Isola M; Mazzaro C; Scaini P; Lenzi M; Campanini M; Naclerio C; Tavoni A; Pietrogrande M; Ferri C; Mascia MT; Masolini P; Zabotti A; Maset M; Roccatello D; Zignego AL; Pioltelli P; Gabrielli A; Filippini D; Perrella O; Migliaresi S; Galli M; Bombardieri S; Monti G
    Arthritis Rheum; 2012 Mar; 64(3):843-53. PubMed ID: 22147661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L11. Hepatitis C virus mixed cryoglobulinemia vasculitis: therapeutic options.
    Cacoub P; Terrier B; Saadoun D
    Presse Med; 2013 Apr; 42(4 Pt 2):523-7. PubMed ID: 23453499
    [No Abstract]   [Full Text] [Related]  

  • 20. [Membranoproliferative glomerulonephritis in patients with cryoglobulinemia complicating hepatitis C virus: report of 11 cases].
    Ben Fatma L; Ben Hamida F; Aoudia R; Goucha R; Kaaroud H; Béji S; Barbouch S; Hedri H; Abderrahim E; Elyounsi F; Ben Abdallah T; Ben Moussa F; Kheder A
    Tunis Med; 2007 Mar; 85(3):220-4. PubMed ID: 17668578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.